Loading...
Loading...
India's dapagliflozin imports from BRAZIL total $38.8K across 30 shipments from 12 foreign suppliers. DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) leads with $13.3K in import value; the top 5 suppliers together control 83.5% of this origin. Leading Indian buyers include INTAS PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for dapagliflozin — a diversified sourcing base with multiple active suppliers from BRAZIL.

DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) is the leading Dapagliflozin supplier from BRAZIL to India, with import value of $13.3K across 8 shipments. The top 5 suppliers — DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO), ACCORD FARMACEUTICA LTDA, DERMA & DERMO COM. PRODS. DERM. FAR, DERMA&DERMO COM.PRODS.DERM.FARM.LTDA(AMHO), DERMA & DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS — collectively account for 83.5% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) | $13.3K | 8 | 34.2% |
| 2 | ACCORD FARMACEUTICA LTDA | $8.6K | 2 | 22.2% |
| 3 | DERMA & DERMO COM. PRODS. DERM. FAR | $5.8K | 2 | 14.8% |
| 4 | DERMA&DERMO COM.PRODS.DERM.FARM.LTDA(AMHO) | $2.7K | 1 | 6.8% |
| 5 | DERMA & DERMO COMERCIO DE PRODUTOS DERMATOLOGICOS | $2.1K | 2 | 5.4% |
| 6 | TORRENT DO BRASIL LIMITEDA | $1.9K | 3 | 4.9% |
| 7 | ZYDUS NIKKHO FARMACEUTICA LTDA | $1.6K | 2 | 4.0% |
| 8 | GLOBAL ORGANIZACAO FARMACEUTICA LTDA | $1.4K | 1 | 3.6% |
| 9 | DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) BRAZIL 30049099 2 3 Erlotinib Tablets 150 mg(Tarceva ) 450 TBS 98 USD 4036468.84 981669.3 - 10 403646.9 - 0 0 537657.7 0
2917978 06/04/2024 H 0903011107 MSN LABORATORIES PRIVATE LIMITED DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) | $788 | 1 | 2.0% |
| 10 | DR. REDDYS FARMACEUTICA DO BRASIL LTDA | $510 | 4 | 1.3% |
| 11 | ZYDUS NIKKHO FARMACEUTICA LIMITEDA | $221 | 2 | 0.6% |
| 12 | DR REDDYS FARMACEUTICA DO BRASIL LIMITEDA | $16 | 2 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED | $8.6K | 2 | 22.2% |
| 2 | MSN LABORATORIES PRIVATE LIMITED | $6.3K | 4 | 16.2% |
| 3 | VEEDA CLINICAL RESEARCH LIMITED | $5.8K | 2 | 14.8% |
| 4 | WATSON PHARMA PRIVATE LIMITED | $5.1K | 3 | 13.2% |
| 5 | AZIDUS LABORATORIES LIMITED | $2.7K | 1 | 6.8% |
| 6 | CLIANS LABS PRIVATE LIMITED | $2.6K | 2 | 6.7% |
| 7 | INVENTIA HEALTHCARE LIMITED | $2.1K | 2 | 5.4% |
| 8 | TORRENT PHARMACEUTICALS LIMITED | $1.9K | 3 | 4.9% |
| 9 | CIPLA LIMITED | $1.4K | 1 | 3.6% |
| 10 | ZYDUS HEALTHCARE LIMITED | $964 | 1 | 2.5% |
| 11 | ZYDUS LIFESCIENCES LIMITED | $695 | 2 | 1.8% |
| 12 | DR.REDDY'S LABORATORIES LTD | $510 | 4 | 1.3% |
| 13 | CLIANTHA RESEARCH LIMITED | $126 | 1 | 0.3% |
| 14 | DR REDDYS LABORATORIES LIMITED | $16 | 2 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Dapagliflozin suppliers from BRAZIL to India include DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO), ACCORD FARMACEUTICA LTDA, DERMA & DERMO COM. PRODS. DERM. FAR. The leading supplier is DERMA & DERMO COM. PRODS. DERM. FARM. LTDA (AMHO) with import value of $13.3K USD across 8 shipments. India imported Dapagliflozin worth $38.8K USD from BRAZIL in total across 30 shipments.
India imported Dapagliflozin worth $38.8K USD from BRAZIL across 30 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Dapagliflozin sourced from BRAZIL include INTAS PHARMACEUTICALS LIMITED, MSN LABORATORIES PRIVATE LIMITED, VEEDA CLINICAL RESEARCH LIMITED. The largest buyer is INTAS PHARMACEUTICALS LIMITED with $8.6K in imports across 2 shipments.
The total value of Dapagliflozin imports from BRAZIL to India is $38.8K USD, across 30 shipments and 12 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
30 Verified Shipments
12 suppliers, 14 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists